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RNA polymerase is the central enzyme in all gene expression. The rpoCY75N 
mutation in the zinc-binding domain of the β’ subunit of E. coli RNA polymerase blocks 
a unique RNA-based mechanism of transcription antitermination utilized by 
bacteriophage HK022 and its relatives. Here, we describe the characterization of mutant 
phage, orc0368, which overcomes the rpoCY75N mutation. The orc0368 genome varies 
from the wild type phage genome by 4 single base pair mutations. Three of these 
mutations were not characterized because they occur in intergenic regions but the fourth 
was chosen for study because of its location between a series of transcription terminators 
and the phage late genes. This mutation was predicted to create a promoter that could 
potentially drive the expression of gene Q, the late gene regulator. This prediction was 
confirmed by cloning the respective regions from the wild type and orc0368 phages into 
a promoter probe vector. Assays of reporter gene activity showed that the sequence 
originating from orc0368 had significant promoter activity when compared to the wild 
type sequence. We suggest that the newly created promoter facilitates the expression of 
phage genes essential for growth on the rpoCY75N strain. However, the small plaque 
phenotype of orc0368 observed on the mutant host suggests that suppression of the 
host rpoCY75N mutation is incomplete. 
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 Bacteriophage are viruses that infect bacterial cells. Once they have infiltrated the 
host, bacteriophage utilize the host cell machinery to produce multiple copies of their 
genome in a process called replication. Bacteriophage also use host cell mechanisms to 
produce protein products from their genetic information by transcribing the DNA into 
RNA (typically messenger RNA, or mRNA) and translating the mRNA into proteins. The 
morphological, or structural, proteins are then assembled into functional phage particles 
which are filled with the replicated phage genomes and ultimately released into the 
environment through cell lysis. Properly timed cell lysis is vital to the success of the 
bacteriophage; premature cell lysis results in the release of non-functional and 
structurally incomplete bacteriophage while failure of cell lysis prevents the release of 
any bacteriophage into the environment [1,2,3]. The bacteriophage uses various 
regulatory mechanisms to control the timing of cell lysis. The research described here 
focused on understanding how phage late genes can be expressed even when a critical 
genetic regulatory mechanism, transcription antitermination, is blocked. 
Phage Infection and Life Cycle
Bacteriophages infect specific host cells by binding to receptors on the cell 
surface, a process mediated by accessory tail proteins on the bacteriophage [4]. Once this 
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association has been made, the bacteriophage is able to insert its genetic material into the 
host cell. The type of genetic material varies between classes of bacteriophage; while 
most phage contain double-stranded DNA sequences, some have genomes composed of 
single-stranded DNA, single-stranded RNA, or double-stranded RNA. Regardless of the 
type of genetic material, once the bacteriophage has successfully inserted its genetic 
material into the host it will enter one of two interconnected life cycles—lytic or 
lysogenic. 
 The lysogenic life cycle involves regulation of phage genes to allow the phage to 
lie dormant in the host cell for an undetermined amount of time. The temperate 
bacteriophage will typically only enter the lytic cycle once the health and viability of the 
host cell is threatened (see Figure 1) [5]. Until then, the bacteriophage exists in the host 
as a prophage, a repressed genetic element. Some phages integrate themselves directly 
Figure 1: Lytic and lysogenic life cycles. Both begin with host cell infection (A). In the lysogenic life cycle, the 
phage genome inserts itself into the host genome (B) or exists as a plasmid (not shown) and is replicated along 
with the host genome (C). Under certain circumstances, the phage will switch over to the lytic life cycle which 
consists of phage replication and synthesis of new viral particles (D). The host is then lysed, releasing phage 
particles into the environment (E) to infect other host cells. 
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into the host genome while others exist as an extrachromosomal plasmid. Both 
integration or existence as a plasmid allow the bacteriophage genome to replicate and 
divide with the host cell [4,5]. The bacteriophage genome is therefore passed along to 
each daughter cell during bacterial cell division in the lysogenic life cycle. 
The lytic life cycle occurs when the phage uses the cell machinery to replicate its 
genome and produce viable phage particles immediately upon infection or upon induction 
from the lysogenic cycle [4,5]. Once the bacteriophage has infected the host, the viral 
genome is rapidly copied and packaged into new bacteriophage structures which are 
newly synthesized from phage genes. The host cell is then lysed through the action of 
endolysin enzymes and other protein products encoded by the bacteriophage [3]. 
Endolysins create holes in the cell wall of the host while other protein products may 
inhibit synthesis of the cell wall material. These activities weaken the cell wall and 
ultimately lead to cell lysis (see Figure 1) [3]. As cell lysis occurs, bacteriophage are 
released into the environment and proceed to infect other susceptible host cells. 
Transcription 
Transcription, the first step in all gene expression, is the process of creating 
transient RNA copies of specific genetic sequences contained in DNA. Transcription is 
catalyzed by a protein complex referred to collectively as RNA polymerase. E. coli RNA 
polymerase consists of six subunits—2 α subunits, β, β’, ω and σ—combined into a 
single functional protein complex called the holoenzyme [5,6]. The σ subunit is involved 
in guiding RNA polymerase to the promoter sequences. These special DNA sequences 
align polymerase with the transcription start site (TSS, usually an Adenine, A, residue) of 
a gene [7]. The σ-subunit is not continuously complexed with the other five subunits and 
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is able to dissociate from the core enzyme once transcription has been initiated. 
Expression of the downstream genes can then occur. A representation of RNA 
polymerase can be seen in Figure 2. In normal transcription, the σ-subunit identifies two 
short DNA sequences, one located 10 base pairs upstream of the TSS (-10 element) and 
one located 35 base pairs upstream of the TSS (-35 element) [5,7]. Taken together, the     
-10 and -35 elements comprise a promoter [7]. 
 
There are several factors that determine the strength of the promoter, i.e. how 
likely the σ-subunit is to bind a promoter and initiate transcription. In general, a strong 
promoter is a promoter readily recognized by RNA polymerase while a weak promoter is 
less readily recognized by RNA polymerase. The promoter elements in strong promoters 
typically conform to a consensus sequence, a genetic sequence that is highly conserved 
across all organisms of the same species. However, it is also possible for a strong 
promoter to contain a -35 element that is considerably different from consensus [8]. This 
is possible through the action of a regulatory protein which binds in the vicinity of the -35 
element, helping RNA polymerase recognize and associate with the promoter despite 
deviation from the -35 consensus sequence [8]. Additionally, the -10 and -35 elements in 
Figure 2: E. coli RNA Polymerase. The holoenzyme consists of 2 α subunits and a β, β’, ω, and σ subunits. The σ 
subunit guides the core enzyme to associate with the DNA at the -35 and -10 promoter sequences and helps initiate 
transcription at the TSS but dissociates after transcription begins. 
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a strong promoter are typically separated by 17 base pairs [7]. The sequence of the base 
pairs between the -10 and -35 elements is somewhat determinant of the strength of the 
promoter, but the number of base pairs between the elements (17) is more important in 
determining the strength of the promoter [7,9]. 
A weak promoter is one which does not share much homology with the consensus 
sequence at both the -10 and -35 elements. These promoters are more difficult for the σ-
subunit to identify and therefore associate with to initiate transcription. Weak promoters 
may also have elements separated by more than or less than 17 base pairs [7,9]. In 
general, genes preceded by weak promoters are less likely to be transcribed than genes 
preceded by strong promoters. In E. coli, the consensus sequence for the -10 promoter 
element is 5’-TATAAT-3’ and the consensus sequence for the -35 promoter element is 
5’-TTGACA-3’ [7]. The two elements are separated by 17 base pairs. 
Once RNA polymerase binds to the promoter element sequences, transcription 
begins. During this process, a short segment of the double-stranded DNA is opened and 
one strand is used as a template from which a complementary strand of RNA is 
assembled [6]. The entire assembly of DNA template, RNA product, and RNA 
polymerase is referred to as the ternary complex. The RNA product is single-stranded but 
can associate with itself through complementary base pairing to form secondary 
structures. The secondary structure can provide stability to the RNA molecule and can 
play a regulatory role by affecting stability and translation efficiency [10]. Transcription 
continues until the RNA polymerase reaches a sequence called a terminator. There are 




Rho-dependent, or factor-dependent termination relies on the Rho protein to 
dissociate RNA polymerase from the DNA template once the proper termination signals 
have been recognized within the sequence. Rho is a specialized helicase which binds to 
sequences in the growing RNA strand known as the rut (Rho-utilization) sites, located 
upstream of the actual termination site. Rho then travels along the RNA product until it 
reaches the paused RNA polymerase where it dissociates the RNA from the DNA 
template, terminating transcription and dissociating the ternary complex. This type of 
termination is commonly used by bacteria such as E. coli [5,11]. 
In Rho-independent termination, the terminator exists as a set of inverted 
sequences that create a stem-and-loop structure in the transcribed RNA (see Figure 3). 
The terminator sequence is followed by a string of Adenine bases (A) in the DNA, which 
result in a complementary set of Uracil bases (U) in the RNA [5,12,13]. Base pairing 
bonds between adenine and uracil are relatively weak, meaning the complementary base 
pairs between the DNA and RNA are prone to dissociation [12,13]. Working together, the 
stem-and-loop secondary structure and the complementary A and U base pairs terminate 
transcription; the stem-and-loop structure induces a pause in the movement of RNA 
polymerase along the DNA template, allowing the loosely-bonded adenine and uracil 
Figure 3: Rho-independent termination. Note the stem-loop structure created in the RNA as well as the extended 
complementary sequence of Adenine (A) and Uracil (U) which facilitate dissociation of the two strands from each 
other due to weak bonding between Adenine and Uracil. 
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bases to dissociate from each other, thus dislodging RNA polymerase and terminating 
transcription [5,13]. 
Transcription termination is an important regulatory mechanism for gene 
expression [14]. In lambdoid bacteriophages, the timing of the expression of phage late 
genes, which are involved in cell lysis, is carefully regulated. Transcription terminators 
are thought to help prevent premature cell lysis by preventing premature expression of 
the phage late genes [1,3]. Many bacteriophages, including bacteriophage λ, contain a set 
of terminators upstream of the late genes that prevent the expression of the late genes 
during the lysogenic life cycle and premature expression of these genes during the lytic 
life cycle (see Figure 4) [15]. However, the late genes must be expressed at some point 
during the lytic life cycle to allow assembly of the completed bacteriophage and achieve 
cell lysis [1,4,5,15]. To complete this task, the function of the terminators must be 
overridden in a process known as antitermination. Bacteriophage have evolved several 
ways to suppress transcription termination. 
Antitermination 
 Antitermination is accomplished when antitermination factors interact with RNA 
polymerase to prevent dissociation of the ternary complex at the termination site [6,11]. 
Figure 4: Simplified gene map of bacteriophage λ. Genes are indicated by colored arrows. The structural genes 
(red) and cell lysis genes (purple) are considered the late genes when taken together. Their expression is controlled 
by expression of the genes associated with antitermination (blue arrows) such as Q and N. The yellow arrows 
indicate genes associated with recombination and the establishment of lysogeny after infection. This is not an 
exhaustive map of λ genes. Image created using Geneious software. 
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One type of antitermination in E. coli bacteriophage is protein-mediated antitermination. 
Bacteriophage λ utilizes two separate types of protein-mediated antitermination which are 
mediated by the phage N and Q proteins. The N gene is transcribed and translated into the 
N protein early in the lytic life cycle (see Figure 4) [14]. This protein, along with some 
accessory stabilization factors encoded by the host cell (NUS factors), interact with a 
specific site in the RNA transcript known as the nut (N-utilization) site. The complex 
formed by N and the NUS factors at the nut site interacts with RNA polymerase, 
stabilizing the elongation complex and allowing it to resist Rho-dependent and Rho-
independent termination [14]. Therefore, N-mediated antitermination allows RNA 
polymerase to read through λ terminators and express the genes that lie beyond them. 
Antitermination in λ using the nut site, N and the host-encoded NUS factors 
allows for expression of the downstream Q protein gene. Once produced, Q proceeds to 
interact with the qut (Q-utilization) site on the DNA located downstream of the Q gene to 
prevent the elongation complex from dissociating at the Tr’ terminator [14]. Q 
accompanies the RNA polymerase elongation complex during transcription of the 
downstream sequence [14]. Q helps prevent stalling at downstream terminators and 
therefore permits expression of the late genes required for cell lysis [14]. 
RNA-mediated antitermination represents a different mechanism of suppressing 
transcription termination. Bacteriophage HK022, a relative of λ, uses RNA-mediated 
antitermination to read through terminators and express its genes [16,17,18]. The RNA 
molecule responsible for this type of antitermination is synthesized from the phage put 
(polymerase utilization) sites, putL and putR. The put site RNA forms a double stem-and-
loop secondary structure by self-association as shown in Figure 5 [16,17]. This structure 
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interacts specifically with the β’ subunit of RNA polymerase to change the conformation 
of the elongation complex and allow read-through of terminators. In HK022, RNA-
mediated antitermination by the put site RNA allows for expression of the Q protein. As 
in λ, Q is involved in protein-mediated antitermination and allows expression of the late 
genes required for cell lysis. The mechanism for RNA-mediated antitermination is 
illustrated in Figure 6. 
Antitermination does not always occur with 100% efficiency. This is important in 
the coordination of bacteriophage gene expression and the timing of cell lysis [1]. In λ, 
control of antitermination is also essential in determining which life cycle the phage will 
enter [19]. In RNA-mediated antitermination, the structure of the RNA is essential for 
antitermination—the sequence of the RNA may vary so long as base pairing is 
Figure 5: Double stem-and-loop structure in RNA-mediated antitermination. As the RNA from the put site exits 
RNA polymerase, it associates with itself to form a secondary structure composed of two interconnected stem-and-
loop components. This secondary structure interacts with the β’ subunit of RNA polymerase to change the 
polymerase to a terminator-resistant form, allowing it to read through the terminators and transcribe Q which then 
proceeds to antiterminate at the Tr’ terminator to express the downstream late genes [17]. 
Figure 6: RNA-mediated antitermination. RNA polymerase binds at the promoter and begins transcription (A). As 
it transcribes the put site (box) contained in the DNA sequence, the put RNA folds into the double stem-and-loop 
structure and interacts with RNA polymerase (B). When RNA polymerase reaches the terminator, the put RNA 
prevents dissociation, transcription continues, and antitermination is accomplished (C). 
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maintained and the double stem-and-loop structure in Figure 5 is conserved 
[16,17,18,19]. 
The E. coli rpoCY75N Mutant 
Because RNA polymerase is the central enzyme in all gene expression, mutations 
in RNA polymerase have the potential to directly affect gene expression. Certain 
mutations in E. coli RNA polymerase can prevent bacteriophage gene expression by 
interrupting antitermination mechanisms [20,21]. If expression of the late genes is 
prevented by the mutant RNA polymerase, the bacteriophage will be unable to synthesize 
phage particles and lyse the host cell; in other words, phage growth is blocked. During 
the characterization of antitermination in HK022, a mutant E. coli strain was isolated that 
blocks phage growth by preventing RNA-mediated suppression of transcription 
termination [20,21]. This E. coli strain was named rpoCY75N because it contains a 
mutation in the rpoC gene, which encodes the β’ subunit of RNA polymerase. The 
rpoCY75N mutation creates a single amino acid change from Tyrosine (Tyr) to 
Asparagine (Asn) in the highly-conserved zinc-binding region of the β’ subunit as seen in 
Figure 7 [20,21]. This single amino acid substitution prevents RNA-mediated 
antitermination by preventing the association of the put site RNA transcript with RNA 
polymerase at the β’ subunit. The mechanism for this failed interaction is displayed in 











Reporter Vectors  
Figure 7: The location of the 
rpoCY75N mutation. The mutation 
creates a single amino acid change from 
Tyrosine (Tyr) to Asparagine (Asn) at 
position 75 in the β’ subunit, within the 
zinc-binding region of the enzyme. 
Figure 8: The prevention of RNA-mediated antitermination by the rpoCY75N mutation. RNA polymerase binds to 
the DNA at the promoter and begins transcription (A). The put site is transcribed but the RNA construct is unable 
to interact with RNA polymerase (B). Transcription is terminated when RNA polymerase reaches the terminator 
and the ternary complex dissociates (C). 
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Plasmids are small, circular, extra-chromosomal, double-stranded DNA genetic 
elements which can replicate independently of the host cell [5]. Plasmids may exist in 
single or multiple copies within an individual host cell [5]. Plasmids can supply many 
non-essential yet evolutionarily advantageous genes to their host cell including virulence 
factors like toxins and antibiotic resistance [4,5]. Some plasmids, genetically re-designed 
into configurations known as reporter vectors, are used to test for promoter activity in a 
DNA sequence [22]. Promoter probe vectors are reporter vectors used to quantify the 
activity of hypothesized promoter sequences by measuring expression of a reporter gene 
product such as green-fluorescent protein (GFP) or β-galactosidase [5,22]. The basic 
configuration of a promoter probe vector consists of an origin of replication, an 
antibiotic-resistance gene, a reporter gene, and a multiple cloning site (MCS). 
Promoter activity can be assessed through the observation of reporter gene 
activity. Promoter probe vectors containing the lac operon produce β-galactosidase, an 
enzyme which can cleave lactose as seen in Figure 9 [5]. The lac operon also produces 
other enzymes associated with lactose metabolism [5]. Cleavage of lactose by β-
galactosidase produces galactose and glucose, sugars which the cell can use in 
fermentation reactions for energy. Fermentation produces organic acids which lower the 
pH of the cell and the surrounding environment [23]. The acidic pH is detected by using 
pH indicators such as neutral red which are easily incorporated into agar plate media. 
Cells expressing β-galactosidase appear red on these indicator plates [23]. This assay can 
be used to qualitatively determine if promoter activity is present in the inserted sequence.  
Alternative galactosides that produce colored products can be used in place of 
lactose to quantitate promoter activity. Examples include X-gal and ONPG (o-
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nitrophenyl galactoside). ONPG is used in the Miller Assay to indirectly measure the 
strength of the promoter by determining the enzymatic activity of β-galactosidase, which 
is related to the amount of β-galactosidase expressed in the cells. When ONPG is cleaved 
by β-galactosidase it produces a bright yellow product which is easily measured 
spectrophotometrically (Figure 9) [5]. Using data gathered from spectrophotometric 
analyses, reaction time, and cell culture density, quantitative assessments of promoter 
activity can be obtained. 
 
  
Figure 9: β-galactosidase activity. β-galactosidase cleaves the lactose sugar dimer, producing substrates for 
fermentation reactions in the host (A). Fermentation generates organic acids which result in an acidic pH. β-
galactosidase also cleaves the substrate ONPG into galactose and o-nitrophenol, which has a characteristic bright 






MATERIALS AND METHODS 
 
Bacteriophages 
 Bacteriophage 0276 is a Lambda-HK022 hybrid E. coli phage [18]. Phage 0276 is 
mainly comprised of the λ genome and includes the b519 and b515 deletions which 
remove non-essential genes [18]. Hybrid phage 0276 also contains the immunity region 
of the HK022 genome, including the nun, cI, cro, and cII genes as well as the RNA-
mediated antitermination sites, putR and putL (see Figure 10) [17,18]. RNA-mediated 
antitermination is necessary for expression of Q and the late genes in 0276. 




Figure 10: Alignment of hybrid phage 0276 genome with parental phage λ genome. Homology is denoted by the 
continuous green bar at the top. Gaps in homology around base pairs 20,000 and 25,000 are the λ b519 and b515 
deletions in 0276. Lack of homology around base pair 35,000 represents the immunity region of HK022, including 




Promoter Probe Vector: pRAK31 
The reporter plasmid pRAK31, a derivative of promoter probe vector pRS415, 
was used to assess the activity and relative strength of suspected promoter sequences 
[22]. The plasmids differ only by the inclusion of approximately 300 base pairs of 
HK022 sequence within the MCS of pRAK31 [16]. This insert was removed by 
restriction digest with EcoRI and BamHI enzymes. pRAK31 confers Ampicillin 
resistance on the host cell and encodes β-galactosidase. A set of four T1 terminators are 
positioned downstream of AmpR and upstream of the MCS and the lacZ reporter gene 
[16]. The MCS contains restriction sites for restriction enzymes EcoRI, BamHI, and 
SmaI [16]. The structure of pRAK31 after excision of HK022 sequence is shown in 
Figure 11. 
In the pRAK31 reporter vector used in this study, the reporter gene is positioned 
downstream of a set of transcription terminators on the plasmid. The MCS includes 
several restriction sites at which a DNA sequence of interest may be inserted. If the 
Figure 11: pRAK31 without 
the HK022 insert. Note the 
AmpR gene which confers 
Ampicillin resistance as well 
as the set of 4 T1 terminators 
(orange) located before the 
MCS (grey). The lac operon, 
including lacZ, lacY, and lacA 
is located after the terminators 




inserted test sequence has promoter activity, then the reporter gene will be expressed. If 
the sequence does not have promoter activity, then any transcription initiated at sites in 
the plasmid is terminated at the terminators located upstream of the reporter gene, 
preventing expression of the reporter gene. 
Bacterial strains  
 Bacterial strains used in this study are listed and described in Table 1.  
Table 1. Strains of E. coli 
STRAIN NAME GENOTYPE SOURCE 
MC1000 
Δ(lac)X74 (lac operon 
deletion) 
Silhavy et al [34] 
MG1655 wild type E. coli Singer et al [35] 
RK899 rpoCY75N mutant Weisberg, NIH [36] 
 
Plasmid Isolation and Preparation 
To obtain purified pRAK31 for cloning, a 100 mL overnight culture of strain 
RAK31 was grown in LB media with Ampicillin (100μg/mL final concentration) in a 
37°C shaking incubator (see Appendix A). The cells were harvested and the plasmids 
isolated and prepared for digestion using the QIAGEN QIAfilter midi Kit (Catalog No. 
1243). The protocol for plasmid isolation according to the kit is as follows: 
The 100 mL culture was split into 25 mL aliquots in 4 Oakridge tubes and 
centrifuged at 3,500 x g at 4°C for 10 minutes. The supernatant was poured off and the 
pelleted cells were suspended 4 mL P1 buffer with RNAse A (100μg/mL final 
concentration). Four milliliters of P2 buffer was added to the Oakridge tube containing 
the suspended cells and the tube was quickly inverted several times until the solution 
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became viscous, indicating cell lysis. The Oakridge tube containing the cells was then 
incubated at room temperature for 5 minutes. Meanwhile, a QIAfilter cartridge was 
capped and placed in a tube rack. After the incubation period, 4 mL of chilled P3 buffer 
was added to the Oakridge tube and the tube was inverted several times. The lysed cells 
were poured into the capped QIAfilter cartridge and allowed to incubate at room 
temperature for 10 minutes. 
Filtering the Lysate and Binding the DNA 
 While the lysed cells were incubating at room temperature, a QIAGEN-Tip 100 
column was equilibrated using 4 mL of buffer QBT. A plunger was inserted into the 
QIAfilter, the filter was uncapped, and the lysate was deposited directly into the 
equilibrated QIAGEN-Tip 100 column. The plasmid DNA was bound to the column as 
the filtrate flowed through by gravity. 
Washing and Eluting the Plasmid DNA 
 The plasmid DNA bound to the column was washed with two 10 mL aliquots of 
buffer QC. The QIAGEN-Tip 100 was then transferred to a clean collection tube and the 
DNA eluted from the column with 5 mL of buffer QF. 
Precipitating, Resuspending, and Quantifying Plasmid DNA 
 To concentrate the DNA, 3.5 mL of 100% isopropanol was added to the eluted 
DNA and the contents of the tube was mixed thoroughly. The DNA solution was divided 
into 1 mL aliquots in 1.5 mL microcentrifuge tubes and centrifuged at 13,400 x g at 4°C 
for 30 minutes. After centrifugation, the supernatant was poured off and the tubes 
inverted to dry. The DNA from all tubes was resuspended in 100 μL (total volume) of 
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elution buffer (EB; QIAGEN; No. 1014608). The tubes were rinsed with another 20 μL 
of EB for a total of 120 μL of DNA solution in EB. 
Measuring Eluted pRAK31 Concentration with the NanoDrop 
 The concentration of the resuspended plasmid DNA was measured using a 
NanoDrop spectrophotometer (ThermoFisher Scientific; No. ND-2000). The pedestal of 
the spectrophotometer was cleaned with a KimWipe and blanked with 2 μL EB. The 
pedestal was dried with a KimWipe and 2 μL of the DNA sample was placed on the 
pedestal. The concentration of the sample was measured in ng/μL and protein or RNA 
contamination was assessed using the measured A260/280 ratio. 
Plasmid Digestion: Double Digestion 
 A set of restriction digests were performed on the purified plasmid DNA using 
EcoRI and BamHI enzymes. The digestion process removed the HK022 sequence from 
the MCS of the plasmid and created “sticky ends” on the remaining section of the 
plasmid. Sticky ends allow for the ligation of a fragment of DNA with complementary 
sequences to the linearized plasmid, restoring the circular construct. The restriction 
digests performed on pRAK31 were double digests in which BamHI and EcoRI enzymes 
were used simultaneously. The digestion reactions were prepared in 5 PCR tubes 
according to the outline below and incubated in a MJ Research PTC-200 Thermal Cycler 
(GMI; SKU 8252-30-0001) at 37°C for 2 hours. The volume of nanopure water and 






X μL Nanopure water 
X μL pRAK31 DNA (approx. 4 μg) 
3 μL 10X EcoRI buffer (New England BioLabs; No. B0101S) 
1 μL EcoRI restriction enzyme (New England BioLabs; 20,000 u/mL; No. R0101S) 
1 μL BamHI restriction enzyme (New England BioLabs; 20,000 u/mL; No. R0136S) 
30 μL Total reaction volume 
 
Restriction Digest Cleanup 
 The restriction digests were purified by removing the reaction components using 
the E.Z.N.A. Cycle Pure Kit (OMEGA bio-tek; No. D6493-01). The instructions included 
with the kit are as follows. 
Collect and Wash DNA 
 Digested plasmid from all 5 PCR tubes was combined into one microcentrifuge 
tube. Eight hundred microliters of CP buffer was added and the microcentrifuge tube 
vortexed. Two filters from the kit were placed in collection tubes and 500 μL of the DNA 
and CP buffer was added to each column. The columns were centrifuged at 10,000 x g for 
1 minute and the filtrate discarded. Two washes with DNA wash (700 μL wash, 10,000 x 
g for 1 minute) were performed. 
Elute and Measure the Concentration of the Digested Plasmid DNA 
 The column containing the DNA was centrifuged at 10,000 x g for an additional 
2.5 minutes to remove any residual wash solution, then transferred to a clean collection 
tube. Fifty microliters of EB buffer was added to the center of the column and incubated 
at room temperature for 2 minutes. The column was then centrifuged at 10,000 x g for 3 
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minutes to elute the digested plasmid DNA. The concentration of the DNA was measured 
using the NanoDrop spectrophotometer. 
Agarose Gel Electrophoresis and Confirmation of Plasmid DNA Integrity 
 One method for confirming the presence or absence of a sequence of known size 
is gel electrophoresis. Gel electrophoresis makes use of the natural negative charge of 
DNA to separate DNA fragments when exposed to an electrical current. The DNA 
samples are loaded into a hardened gel made by dissolving the polysaccharide agarose in 
buffer. Once an electrical current is applied to the gel, the DNA migrates through the 
matrix towards the positive electrode. Small fragments pass through the porous matrix 
more readily than large fragments and therefore migrate faster than large fragments. This 
effectively resolves the DNA fragments in the sample by size. The ratio of agarose to 
buffer, measured in percent weight-to-volume ratio, determines the resolving power of 
the gel; a higher percentage gel has a higher resolving power. A ladder, or set of DNA 
fragments of known size, is also run on the gel. This allows for approximation of the 
fragment sizes when visualized. Visualization is accomplished by staining the gel with 
ethidium bromide, an intercalating agent that fluoresces with UV excitation at 300 and 
360 nm wavelengths. A camera with a filter specific for the emitted wavelengths can be 
used to image the gel under UV light to visualize the DNA fragments. 
 To visualize the digested plasmid and the released HK022 sequence, the purified 
DNA was run on a 1.5% agarose gel. This gel was prepared by adding 0.6 grams of 
agarose powder (Fisher BioReagants; BP160-100) to 40 mL of 1X TAE buffer (see 
Appendix A). The agarose and 1X TAE were heated in the microwave until the agarose 
was thoroughly dissolved, cooled to approximately 55°C on the lab bench, and poured 
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into a gel rig containing a comb to create wells for the DNA samples. Once the agarose 
had hardened, the comb was removed and the gel oriented in the rig so the wells were 
near the negative electrode. The rig was filled with 1X TAE buffer until the gel was 
submerged in the buffer by approximately 0.5 cm. Five microliters of digested pRAK31 
plasmid DNA was mixed with 2 μL of loading dye (see Appendix A) for visualization 
and then placed in a well of the agarose gel. Five microliters of λ-HindIII ladder 
(Fermentas; 0.5 mg/mL; No. SM0101) was also mixed with 2 μL loading dye and loaded 
into a separate well in the gel. The agarose gel was run at 120 volts for approximately 50 
minutes. 
 The DNA in the agarose gel was stained with ethidium bromide solution (0.5 
μg/mL final concentration in 1X TAE buffer; Sigma-Aldrich 10 mg/mL stock; E1510-10 
mL) for 15 minutes. The stained gel was exposed to UV light and imaged using an Alpha 
Innotech FluorChem HD2 (S/N: 504332; EPI UV Lights: Dual 254/365 nm). This image 
was used to assess the integrity of the digested pRAK31 plasmid and confirm the release 
of HK022 sequence. 
Gel Purification and Phenol-Chloroform Extraction of Plasmid DNA 
 A set of three 1.2% agarose gels were prepared by heating 120 mL of 1X TAE 
buffer with 1.44 grams of agarose powder until the agarose was dissolved. Three gels 
were made using 3 aliquots of 40 mL each. The gels were cooled and submerged in 1X 
TAE and 60 μL of loading dye was mixed into 200 μL of double-digested DNA. Twenty 
individual wells were filled with 10 μL each of the DNA mixture. The gels were run at 
120 volts for approximately 1.25 hours, then stained with ethidium bromide. 
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 The gel was placed on a UV light box and the UV light turned on. The target 
bands were promptly cut from the gel with a straight razor in a thin fragment without 
including excess agarose gel. The UV light source was immediately turned off to avoid 
damaging the DNA. The thin fragment of gel containing the plasmid DNA was cut into 4 
pieces of equal size and placed in 4 microcentrifuge tubes. The pieces of gel were then 
minced into smaller fragments using an 18-gauge needle to increase the surface area of 
the gel. 
 Eight hundred microliters of phenol (Fisher BioReagants; BP1750’-100) was 
added to each microcentrifuge tube containing the minced gel fragments to denature any 
remaining proteins. The tubes were then frozen at -80°C for 20 minutes. The samples 
were removed from the -80°C freezer and centrifuged at 10,000 x g at room temperature 
for 10 minutes to separate the aqueous layer containing the DNA from the phenol layer. 
The upper aqueous layer was extracted from each microcentrifuge tube and aliquoted in 
400 μL increments into clean 1.5 mL microcentrifuge tubes. To remove remaining 
phenol, chloroform extractions were performed by adding 400 μL of chloroform (Fisher 
Chemical; C298500) to each tube and vortexing to mix the aqueous layer with the 
chloroform. Each tube was centrifuged on a quick spin (10,000 x g for 15 seconds) at 
room temperature to separate the layers. 
 The upper aqueous layer of each tube was collected and placed into a clean 
microcentrifuge tube. Extraction with 400 μL of chloroform was repeated once more to 
remove any residual traces of phenol from the sample. The final volume of the extracted 
aqueous layer was measured using a pipet and noted on the top of each tube. One-tenth of 
the final volume of the aqueous layer was calculated and this volume of 3 Molar sodium 
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acetate (pH 5.2) was added to each tube. Twice the final volume of the aqueous layer 
denoted on the top of the tube was also calculated, and this volume of chilled 100% 
ethanol was added to each tube and mixed well. The tubes were incubated at -20°C 
overnight to precipitate the DNA. 
Removal of Salts by Buffer Exchange 
 The presence of residual salts from gel purification and extraction can be 
detrimental to success of subsequent experimental procedures including ligation and 
electroporation. To prevent negative outcomes, the digested plasma DNA was transferred 
from the aqueous layer of the chloroform extractions to EB using buffer exchange. DNA 
was recovered from ethanol precipitations by centrifuging the tubes at 10,000 x g at 4°C 
for 30 minutes. The supernatant was removed and the pelleted DNA suspended in 100 μL 
(total volume) of EB. The tubes were rinsed with an additional 50 μL EB for a total of 
150 μL of EB containing DNA. 
 Two Amicon Ultra Centrifugal Filter Units (Sigma Aldrich; 0.5 mL, UFC 
510096) were placed in collection tubes and 350 μL EB added to each unit. Seventy-five 
microliters of the resuspended plasmid DNA was added to each filter unit and centrifuged 
at 6,600 x g for 3 minutes at room temperature. The filtrate was discarded from the 
collection tube and 400 μL EB added to each filter unit. The units were centrifuged at 
6,600 x g for 5 minutes, after which they were transferred to clean collection tubes. Fifty 
microliters of EB was pipetted down the sides of each filter unit to facilitate the recovery 
of the DNA. The filtration unit was inverted in the collection tube and centrifuged at 




Amplification of Predicted Promoter Sequences using PCR 
 Polymerase Chain Reaction (PCR) amplifies target genetic sequences. Here it was 
used to synthesize multiple copies of a predicted promoter sequence which were then 
ligated with pRAK31. PCR utilizes a directionally-oriented set of sequence-specific 
primers, one for each strand of double-stranded template DNA, as well as free 
nucleotides and polymerase enzyme. Primers RK814, RK812, and RK815 (Table 2) were 
designed to amplify the desired regions of orc0368 and 0276 bacteriophage genomes 
(mutant and wild type bacteriophage, respectively) as shown in Figure 12. The bolded 
sequences, G/GATCC and G/AATTC, are the cut sites for the restriction enzymes 
BamHI and EcoRI respectively. These recognition sites were included in the primers to 
create sticky ends that facilitated ligation to the pRAK31 vector. 
Table 2. Oligonucleotide Primers 
Primer Sequence and Orientation 
RK812 5’—gatcggatccGCGGTTATGGTTTGATTCG—3’ (reverse) 
RK814 5’—cgatcgaattcGCGGAAATCTCGTTCCGT—3’ (forward) 
RK815 5’—gatcggatccGTGAAGGGATAGCTCTCAC—3’ (reverse) 
 The PCR product synthesized using RK812 and RK814 (RK812 x RK814) is 86 
base pairs long. The product synthesized using RK815 and RK814 (RK815 x RK814) is 
130 base pairs long. Reactions were set up for the short and long products as follows: 
Figure 12: Location of primers RK814, RK812, and RK815 in the orc0368 genome. The green bar indicates 
homology with bacteriophage 0276. The gap in the green bar indicates a substitution mutation in orc0368 at base 
pair 36,395. Image created using Geneious software. 
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 Four total PCR were prepared: RK812xRK814 and RK815xRK814 reactions 
using both 0276 and orc0368 for template DNA. Phage 0276 was used as a control as it 
had no suspected promoter activity. Reagents were combined in the order listed above 
into 4 separate PCR tubes and mixed well before being run on the following cycle in a 
MJ Research PTC-200 Thermal Cycler: 
Table 3. PCR Reaction Conditions 
  Temperature (°C) Duration (minutes) 
Step 1 94 2 
Step 2 94 0.5 
Step 3 55 0.5 
Step 4 72 1 
Step 5 Repeat from step 2 for 30 repetitions 
Step 6 4 forever 
Step 7 END 
 The success of the PCR was confirmed by running the products on a 1.5% 
agarose gel. A 100 base pair ladder (Axygen; M-DNA-100bp) was included on the gel. 
The gel was stained with ethidium bromide, visualized with UV light, and imaged. The 
PCR products were purified using the E.Z.N.A. Cycle Pure Kit and the concentrations 
measured using the NanoDrop spectrophotometer. 
PCR Setup for Amplifying Suspected Promoter Sequence from orc0368 
and Corresponding Sequence in 0276  
30 μL PCR mix (see Appendix A) 
2 μL DNA template (phage lysate, either orc0368 or 0276) 
1 μL Forward primer (RK814) 
1 μL 
Reverse primer (RK812 for short fragment, RK815 for long 
fragment) 
1 μL Taq Polymerase (Fisher Scientific; 5000 u/mL; FB600015) 
35 μL Total reaction volume 
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Double Digest of PCR Products 
 PCR products RK812 x RK814 and RK815 x RK814 were double digested using 
EcoRI and BamHI. The 4 reactions were prepared as shown below and incubated in the 
MJ Research PTC-200 Thermal Cycler at 37°C for 2 hours. 
Double Digest of PCR Products 
35 μL DNA (PCR product) 
5 μL Nanopure water 
5 μL 10X EcoRI buffer (New England BioLabs; No. B0101S) 
3 μL BSA (New England BioLabs; 10mg/mL; No. B9001S) 
1 μL EcoRI enzyme (New England BioLabs; 20,000 u/mL; No. R0101s) 
1 μL BamHI enzyme (New England BioLabs; 20,000 u/mL; No. R0136S) 
50 μL Total reaction volume 
 The digested PCR products were examined on a 1.5% agarose gel. Once the 
integrity of the sample was confirmed, the enzymes and buffer were removed from the 
double digest reaction using the E.Z.N.A. Cycle Pure Kit. The concentration of each of 
the double-digested PCR products was measured using the NanoDrop spectrophotometer. 
Ligating PCR Product and the Promoter Probe Reporter Vector 
 Ligations were performed to insert the suspected promoter sequence and control 
sequence into the plasmid and restore the circular nature of the reporter vector. Vector-
only control ligation reactions were performed without PCR product to assess the 
efficiency of plasmid digestion and prevalence of undesired recombination events. 
Digested pRAK31 contains incompatible sticky ends preventing the recircularization of 
the plasmid and expression of AmpR. Cells that acquire a non-functional, linear plasmid 
during transformation are unable to grow on media containing Ampicillin. Bacterial 
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colonies resulting from vector-only control ligations are a result of either a failed 
restriction digest prior to ligation or an illegitimate recombination event in pRAK31 
which allows expression of AmpR. The prevalence of colonies in vector-only controls can 
be used to assess these events. 
 Ligations and vector-only controls on both orc0368 and 0276 RK812 x RK814 
and RK815 x RK814 PCR products were set up in PCR tubes as follows. 
Ligation Reactions 
8 μL pRAK31 DNA (double-digested) 
7 μL Nanopure water 
2 μL PCR product (orc0368 or 0276; long or short) 
2 μL 10X T4 ligase buffer (New England BioLabs; No. B0202S) 
1 μL T4 ligase enzyme (New England BioLabs; 400,000 u/mL; No. M0202S) 
20 μL Total reaction volume 
 
Vector-only Control Ligation Reactions 
8 μL pRAK31 DNA (double-digested) 
9 μL Nanopure water 
2 μL 10X T4 ligase buffer (New England BioLabs; No. B0202S) 
1 μL T4 ligase enzyme (New England BioLabs; 400,000 u/mL; No. M0202S) 
20 μL Total reaction volume 
 
 These reactions were incubated at 14°C overnight in the MJ Research PTC-200 
Thermal Cycler. Salts from reaction buffer was removed using Amicon Ultra Centrifugal 
Filter Units to prevent interference with electroporation during transformation. Nanopure 
water was used to complete the washes and the recovery of the DNA. The purified-
ligation reactions were vacuum evaporated in a CentriVap Concentrator (LABCONCO; 
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No. 7810000) at 29°C until the ligations were reduced to about 10 μL in volume. 
Resulting vectors were named and are listed in Table 4. 
Table 4. Reporter Vector Constructs and Corresponding Transformed E. 
coli Strains 
PLASMID NAME INSERTED SEQUENCE CORRESPONDING STRAIN 
pRK1387 RK812 x RK814, orc0368 RK1387 
pRK1388 RK815 x RK814, orc0368 RK1388 
pRK1390 RK812 x RK814, 0276 RK1390 
pRK1391 RK815 x RK814, 0276 RK1391 
 
Transformation by Electroporation 
 The vectors were inserted into E. coli cells and plated on indicator plates to 
determine whether the inserted sequences had promoter activity. The E. coli cells used 
for transformation must be electrocompetent, or receptive to the insertion of the plasmid. 
[6] A rapid pulse of electric current is applied to a mixture of competent cells and vector 
to induce them to take in the vector. 
 A stock of electrocompetent MC1000 cells was prepared as follows. An overnight 
culture of the cells was grown in 5ml of LB media in a shaking incubator at 250 rpm and 
37°C. A 100 μL aliquot of overnight cells was added to 100 mL of LB media which was 
replaced in the shaking incubator and grown to an optical density (OD650) of 
approximately 0.5. The culture was removed from the incubator and split between into 
two 50 mL aliquots in two 50 mL conical tubes and cooled on ice. After growth was 
arrested by chilling the culture, the tubes were centrifuged at 4,400 x g for 10 minutes at 
4°C and the supernatant removed. The pelleted cells were suspended in 25 mL of ice-cold 
29 
 
10% glycerol. An additional 25 mL of ice-cold 10% glycerol was added to the suspended 
cells. The cells and glycerol were mixed well and centrifuged at 4,400 x g and 4°C for 12 
minutes. After the supernatant had been removed, the cells were suspended in another 25 
mL aliquot of ice-cold 10% glycerol and centrifugation was repeated. The supernatant 
was again removed and the pellet was suspended in 1.5 mL of ice-cold 10% glycerol. The 
cells were then transferred from the 2 conical tubes to 2 microcentrifuge tubes. These 
were centrifuged at 6,000 x g and 4°C for 12 minutes, the supernatant removed, and the 
cells suspended in 300 μL ice-cold 10% glycerol. These electrocompetent cells were 
divided into 40 μL aliquots and stored at -80°C until electroporations were performed. 
 To perform electroporations, 40 μL of electrocompetent MC1000 cells were 
combined with 5 μL of each purified ligation reaction and mixed well. The cells and 
ligations were transferred to a 2 mm electroporation cuvette (BioExpress; No. E5010-2) 
and were electroporated (2.5 kV, 2 mm gap). Nine hundred microliters of Super Optimal 
Broth (SOC Broth; see Appendix A) was used to suspend the cells in the cuvette. The cell 
suspension was transferred to a 15 mL conical tube and incubated at 37°C and 250 rpm 
for 1 hour. 
 After incubation, 50 μL, 100 μL, and 150 μL aliquots of the transformed cells 
were spread aseptically onto MacConkey-Lactose plates with Ampicillin (Mac-Lac-Amp, 
see Appendix A). These plates were incubated at 37°C overnight. Transformants 
appearing on the plates after the overnight incubation were assessed qualitatively for 
promoter activity based on their apparent color. Colonies displaying the desired color 
phenotype for the transformed plasmid were streaked onto fresh Mac-lac-Amp plates, and 
incubated overnight at 37°C. The presence of the target sequence in the transformants 
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was confirmed using whole-cell PCR.  The sequence of the PCR products from positive 
clones was confirmed. Cells were named according to the transformed vector as 
described in Table 4. 
Whole-Cell PCR 
 To verify the presence of the suspected promoter sequence from orc0368 and the 
corresponding sequence from 0276 in the vector, the region of the vector containing the 
insert was amplified and sequenced. Primers RK814 and RK1, a primer complementary 
to a region within the lacZ gene of the vector, were used to amplify the inserted sequence. 
The resulting amplicons were 126 bp from insert RK812 x RK814 in pRK1387 and 
pRK1390 and 180 bp from insert RK815 x RK814 in pRK1388 and pRK1391. The 
reactions were set up as follows and run in the MJ Research PTC-200 Thermal Cycler on 
the program outlined in Table 3. 
Whole-Cell PCR on Transformants 
38 μL Nanopure water 
5 μL 10X buffer (Fisher Scientific Kit; FB-6000-10) 
4 μL dNTPs (Fisher Scientific Kit; FB-6000-10) 
1 μL Forward primer (RK814) 
1 μL Reverse primer (RK1) 
1 μL Taq Polymerase (Fisher Scientific; 5000 u/mL; FB600015) 
50 μL Total volume 
 The PCR products were confirmed on a 1.5% agarose gel. The products were 





DNA Sequencing of Inserts 
 The sequence of the insert was confirmed using dideoxy sequencing. Dideoxy 
sequencing utilizes a large number of arrested polymerizations performed with regular 
nucleotides and fluorescent dideoxy-nucleotides to determine the order of bases in a 
DNA fragment. During polymerization, DNA is synthesized normally with the addition 
of regular nucleotides. When a dideoxy-nucleotide is added to the growing strand of 
DNA, polymerization is permanently halted, leaving the fluorescent base as the terminal 
base of the strand. The order of bases in a sequence can be determined by aligning the 
strands of DNA by length and exciting the terminal bases with fluorescence. The 
fluorescent signals produced by the tagged nucleotides are recognized with a sequencing 
machine and assembled into a comprehensive sequence of base pairs. Reactions were set 
up as follows, with variable volumes of water and DNA according to the concentration of 
the DNA measured using the spectrophotometer. 
Sequencing Reactions 
X μL DNA from PCR (200 ng) 
2 μL 
5X sequencing buffer (Applied BioSystems BigDyeTM Terminator v3.1 
Cycle Sequencing Kit; No. 4337455) 
1 μL RK1 primer 
X μL Nanopure water 
2 μL 
Sequencing juice (Applied BioSystems BigDyeTM Terminator v3.1 Cycle 
Sequencing Kit; No. 4337455) 
10 μL Total volume 
 The sequencing reactions were run in the MJ Research PTC-200 Thermal Cycler 
according to the conditions outlined in Table 5. 
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Table 5. Sequencing Conditions 
  Temperature (°C) Duration (minutes) 
Step 1 96 0.5 
Step 2 50 0.25 
Step 3 60 4 
Step 4 72 1 
Step 5 Repeat from step 1 for 24 repetitions 
Step 6 10 forever 
Step 7 END 
 
 Excess nucleotides and enzymes were removed from the sequencing reactions 
using a SigmaSpin Sequencing Reaction Cleanup Kit (Sigma-Aldrich; No. S5059-70EA) 
according to the protocol provided with the kit. Each sequencing reaction was completely 
evaporated using the CentriVap, after which it was resuspended into 20 μL of formamide. 
The samples were loaded into an ABI3130 Automated Capillary Sequencer and then 
sequenced. 
Quantitative β-galactosidase Assays 
 The promoter activity of both RK812 x RK814 and RK815 x RK814 sequences 
from orc0368 and 0276 was quantitatively assessed using a β-galactosidase assay. 
Cultures of the transformed MC1000 cells were grown overnight in LB media with 
Ampicillin (100 μg/mL) at 37°C and 250 rpm. The cultures were diluted by transferring 
200 μL of overnight culture to 20 mL of LB media with Ampicillin (100 μg/mL) and 
returned to the shaking incubator for 2.5 hours. After 2.5 hours, the OD600 of the cells 
was measured and a 1.5 mL aliquot of each culture was retained on ice while the rest of 
the culture was returned to the incubator for an additional 30 minutes. After a total of 3 
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hours of incubation, the OD600 of the cultures was measured and the cultures were placed 
on ice. β-galactosidase Miller Assays were performed as detailed below. 
 The assays were prepared by adding the following to a 10 x75 mm glass tube. 
β-galactosidase Assays 
0.9 mL Z-buffer (see Appendix A) 
0.1 mL Transformed MC1000 culture 
50 μL 10% SDS (sodium dodecyl sulfate) (see Appendix A) 
100 μL Chloroform 
  
 Each glass tube was vortexed to ensure the cells were exposed to the chloroform.  
Exposure to chloroform permeabilized the cells to allow the substrate for the reaction, o-
nitrophenyl-β-galactoside (ONPG), to interact with the β-galactosidase created by 
expression of the lacZ gene in the vector. The glass tube was incubated in 28°C water 
bath for 5 minutes. After 5 minutes, 200 μL of ONPG (4 mg/mL) was added to the tube, 
mixed thoroughly, and a timer was started. The tube was watched carefully until a bright 
yellow color began to develop at which point 500 μL of 1 Molar sodium carbonate was 
added to the tube to stop the reaction and the time was recorded. To prepare the 
spectrophotometer, a blank was prepared using Z-buffer, 0.1% SDS, chloroform, sodium 
carbonate, and 0.1 mL LB with Amp to replace the culture and 200 μL nanopure water to 
replace the ONPG. This solution was used to blank the spectrophotometer at 420 nm and 
550 nm. The absorbance of each of the reactions was measured and recorded at 420 nm 
and 550 nm. These measurements were inserted into the following equation to determine 
the Miller Activity Units of enzyme activity. The reporter activity thus provides a way to 
estimate the promoter activity for the target sequence derived from orc0368 or 0276. 
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𝑀𝑖𝑙𝑙𝑒𝑟 𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑈𝑛𝑖𝑡𝑠 = 1000 ×
(𝑂𝐷420 − (1.75 × 𝑂𝐷550))




 An overnight culture of strains containing pRK1387, pRK1388, pRK1390, and 
pRK1391 were grown in LB media with Ampicillin (100 μg/mL) from representative 
colonies on Mac-Lac-Amp plates. The cultures were incubated at 37°C and 250 rpm. 
After the cultures were removed from the incubator, the cells were pelleted by 
centrifugation at 3,400 x g for 10 minutes. The supernatant was removed and the pellet 
suspended in 2.5 mL 10 mM magnesium sulfate. An 800 μL aliquot of cells suspended in 
magnesium sulfate was mixed with 200 μL of 80% glycerol in a cryotube. Glycerol acts 
as a cryoprotectant and prevents cellular damage during the freezing process. The 









Because they depend upon host machinery for their development, viruses are 
often used as simple models for studying mechanisms of gene regulation and expression. 
Understanding viral gene regulatory programs is particularly important for understanding 
disease processes and virulence, as both are highly dependent upon regulated gene 
expression. Over time, host cells can evolve mechanisms to resist viral infection. 
However, viruses also mutate and these mutations may allow them to successfully infect 
a non-permissive host. This study was performed to determine how a bacteriophage 
might overcome the block imposed by the host rpoCY75N mutation in E. coli. Sequence 
analysis of a UV-induced bacteriophage mutant suggested that a single base pair mutation 
near the phage Q gene restored phage growth by creating a new promoter element. This 
hypothesis was based on similarities to the byp mutation in λ, named for its ability to 
bypass the need for N-mediated antitermination for phage growth [28]. 
Parental phage 0276, a hybrid phage composed mainly of the λ genome with the 
immunity region of HK022, is incapable of growing on the rpoCY75N host because 
RNA-mediated antitermination is blocked. UV mutagenesis was performed on a stock of 
0276 in an attempt to produce mutant bacteriophage capable of growing on rpoCY75N 
[28]. One of the mutant phages capable of growth on rpoCY75N (see Figure 13) was 
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named orc0368 for its ability to 
overcome the rpoCY75N mutation. 
When sequenced and aligned with 
0276, orc0368 was found to differ 
from 0276 by only 4 base pairs, all of 
which existed as separate single base 
pair mutations. Bioinformatic analysis 
placed three of these mutations, 
occurring at base pairs 138, 6,132, 
and 7,432, in intergenic regions in a 
part of the genome containing structural genes (see Figure 14). The fourth mutation, a 
Guanine to Thymine single base substitution, occurred at base pair 36,395. This mutation 
exists in the region between a set of terminators the phage Q gene (see Figure 14). 
Figure 13: Plaques formed by orc0368 on rpoCY75N E. coli. 
Representative plaques (clearings in the bacterial lawn 
indicating cell lysis) are circled. 
Figure 14: Alignment of 0276 and orc0368 genomes. Homology between the two sequences is indicated by the 
green bar at (A), breaks in which indicate difference in sequence (marked with red arrows). The black bar at (B) is 
0276 sequence; orange arrows are terminators, pink arrows are put (antitermination) sites, and the yellow arrow is 
Q. The black bar at (C) is orc0368 sequence. Note the mutation occurring between the third terminator and Q. 
Image created using Geneious software. 
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This mutation was chosen for analysis and characterization because it occurs in a 
region where mutations that overcome defects in early antitermination in bacteriophage λ 
have previously been described [28,29]. The byp mutation consists of an isolated single 
base pair substitution which brings the sequence closer to the consensus sequence of a     
-10 promoter element [28]. Although neither the -10 nor the -35 elements of the byp 
mutation promoter match the consensus E. coli promoter sequence, the elements are 
separated by the characteristic 17 base pairs present in the consensus promoter. The byp 
mutation functions by providing low but constitutive expression of Q which allows for 
sufficient expression of the late genes to allow plaque formation on the host [28].  
Amplification of Predicted Promoter in orc0368 and Corresponding 0276 Sequence 
To determine if the mutation at base pair 36,395 in orc0368 creates a promoter, a 
region encompassing the predicted promoter sequence from orc0368 and its wild type 
parent, phage 0276, were PCR amplified using the primers listed in Table 2; amplicons 
were produced by using primer pairs RK812 x RK814 and RK815 x RK814. Sequences 
of different lengths were amplified to increase the chances of capturing all the essential 
promoter sequences.  The resolution of these PCR products on a 1.5% agarose gel is 




Gel Purification of pRAK31  
The promoter probe plasmid pRAK31 was double-digested with EcoRI and 
BamHI enzymes. The resulting 
linearized plasmid DNA was run on 
a 1.2% gel to separate the two 
fragments generated by the digest. 
The linearized plasmid was 
significantly longer than the 
released HK022 sequence. The 
difference in size resulted in a 
difference in migration through the 
gel; larger fragments migrate more slowly than smaller fragments, meaning the larger 
Figure 15: Gel confirmations of PCR on orc0368 (A) and 0276 (B). In both (A) and (B), lane 1 contains 100 bp 
ladder. In (A), lane 6 contains RK812 x RK814 (86 base pairs) and lane 7 contains RK815 x RK814 (130 base 
pairs) from orc0368. Lanes 3, 4, and 5 contain PCR products of regions containing the other mutations in orc0368. 
In (B), lane 2 contains RK812 x RK814 and lane 3 contains RK815 x RK814 from 0276. 
Figure 16: Gel-purified plasmid double-digest of pRAK31. The 
target DNA (double-digested plasmid) has been removed leaving 
an empty space on the gel. In contrast, the released fragments 
have been left in the gel and appear below the target DNA due to 
their smaller size relative to the digested plasmid. 
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fragments remain closer to the wells of the gel than smaller fragments. The linearized 
plasmid, or target sequence, was therefore identified as the band of DNA located closest 
to the wells of the gel. The target DNA was purified as described in “Materials and 
Methods: Gel Purification and Phenol-Chloroform Extraction of Plasmid DNA,” the 
result of which is visible in Figure 16. 
Assessment of Promoter Activity using Indicator Plates 
The PCR products containing the suspected promoter sequence were purified and 
double digested with EcoRI and BamHI to generate the appropriate ends for cloning.  
The digested PCR products were ligated into the double-digested and gel purified 
pRAK31 promoter probe plasmid to determine if the amplified sequences have promoter 
activity. The resulting reporter vectors were then transformed into MC1000 cells and 
plated on Mac-Lac-Amp indicator plates. Mac-Lac plates are plates containing the pH 
indicator neutral red and the sugar lactose. If β-galactosidase is produced, lactose is 
Figure 17: Transformations of pRAK31 with inserts from orc0368 (A) and 0276 (B). Note the red colonies 




cleaved and the resulting sugars are used in fermentation reactions. The bacterial colonies 
that produce acid turn dark red due to the pH indicator. Bacteria that do not produce β-
galactosidase do not lower the pH and appear white on Mac-Lac plates. The results of the 
transformed cells containing sequences from orc0368 and 0276 are shown in Figure 17 
and are presented in Table 6.  
Table 6. Transformations on Mac-Lac-Amp Plates 
Strain Insert Origin Primers Red Colonies White Colonies 
RK1387 orc0368 RK812 x RK814 Y N 
RK1388 orc0368 RK815 x RK814 Y N 
RK1390 0276 RK812 x RK814 N Y 
RK1391 0276 RK815 x RK814 N Y 
 
Confirming the Presence of the Insert in the Reporter Vector by PCR 
Whole-cell PCR was performed to confirm the presence of the insert in the 
transformants. The amplicons generated from 0276 and orc368 using the primer pair 








Quantitative β-galactosidase Assays 
Quantitative analysis of the promoter activity was performed using β-
galactosidase assays, also known as Miller activity assays. Timed reactions were run on 
reporter vectors pRK1387, pRK1388, pRK1390, and pRK1391. Cells containing the 
reporter vectors were supplied with ONPG, an artificial substrate for β-galactosidase. If 
o-nitrophenol is produced by cleavage of ONPG, a bright yellow color measurable by 
spectrophotometry will appear. The rate of production of o-nitrophenol, quantifiable in 
units of enzyme activity using the time of the reaction and factors such as cell culture 
density and prevalence of o-nitrophenol, indicates the relative strength of the promoter. 
This strength is assessed in terms of Miller activity units, the equation for which can be 
found in “Materials and Methods: Quantitative β-galactosidase Assays.” Table 7 contains 
Figure 18: Agarose gel confirmation of the inserted sequences from orc0368 (A) and 0276 (B) using primers 
RK814 and RK1. A 100 bp ladder was run alongside the PCR products and is visible in lane 1 (A and B). Lane 2 
(A) and lanes 3 and 4 (B) are the amplicon from the inserted sequence using RK812 x RK814 while lanes 3 (A) 
and lanes 5, 6, and 7 (B) are the amplicon containing the insert from primers RK815 x RK814. Lane 2 (B) is 
representative of a non-existent (failed) ligation, and the DNA visible in this lane is leftover PCR primer. 
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average promoter activity as measured over three separate trials for orc0368 inserts and 
two separate trials for 0276 inserts. 
Table 7. β-galactosidase Assay Results 
Strain Insert Origin Primers 
Average Activity ± Standard 
Deviation (Miller Units) 
RK1387 orc0368 RK812xRK814 133 ± 32 
RK1388 orc0368 RK815xRK814 27 ± 7 
RK1390 0276 RK812xRK814 4.5 ± 0.5 
RK1391 0276 RK815xRK814 8 ± 1 
 










Regulation of gene expression is essential for all organisms, including viruses 
which may switch between distinctly different life cycles (e.g. the lytic and lysogenic 
lifestyles of temperate bacteriophages). Without the proper regulation of gene expression, 
these bacteriophages are unable to switch between the different life cycles or properly 
express their genes to produce new phage particles. Bacteriophage are excellent models 
for exploring genetic regulatory mechanisms and they have provided important insights 
into more complex gene regulation systems found in mammalian viruses or even 
eukaryotic cells. This has implications in multiple fields, particularly the growing field of 
genomic medicine, in which treatments for various diseases are based on the unique set 
of genes expressed by the patient’s own cells. 
The bacteriophage used in this study was bacteriophage orc0368, a mutant 
derivative of the phage 0276, an HK022-λ hybrid. Genomic sequence analysis revealed 
that phage orc0368 differs from 0276 by a total of four base pairs. A single base pair 
change at position 36,395 in the phage orc0368 genome allows the phage to grow on the 
non-permissive rpoCY75N E. coli host. This mutation is located between a set of λ 
terminators and the late gene regulator, Q. Based on bioinformatic analysis and 
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previously characterized mutations in the same region of the λ phage genome, it was 
hypothesized that the substitution mutation at base pair 36,395 created a promoter by 
bringing the sequence closer to the E. coli consensus promoter sequence (see Figure 19). 
This hypothesis was tested by cloning the suspected sequences into a promoter probe 
reporter vector. The presence of promoter activity was supported by qualitative and 
quantitative evidence (see Results). 
The colonies of transformed cells containing constructs pRK1387 or pRK1388, 
both of which contain cloned sequences from orc0368, appeared red on the Mac-Lac 
indicator plates. Colonies containing pRK1387, a construct with an 86 bp amplicon 
generated with primers RK812 x RK814, appeared brighter red than colonies containing 
the pRK1388 construct, which had an amplicon of 130 bp generated with primers RK815 
x RK814. This suggests that both cloned sequences have promoter activity but pRK1387 
generates more activity than pRK1388. Colonies containing pRK1390, a construct with 
an 86 bp amplicon generated with primers RK812 x RK814 from phage 0276, and 
pRK1391, a construct with a 130 bp amplicon generated by primers RK815 x RK814 
from phage 0276, both appeared white on the Mac-Lac indicator plates. This indicates the 
cloned sequences in these constructs do not have promoter activity. Because enzyme 
Figure 19: Comparison of consensus E. coli promoter, 0276, and orc0368 sequences. The -35 sequence is 
separated from the -10 sequence by …(17)… indicating the number of base pairs separating the two sequences. 
The sequence of these 17 base pairs is variable and unrelated to promoter activity. Note that the single base pair 
substitution from G to T in orc0368 as compared to 0276 brings the phage sequence closer to consensus E. coli 
sequence (highlighted and underlined in red). 
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activity reflects promoter activity, these results demonstrate that this mutation in orc0368 
creates a new promoter. 
 The results from the β-galactosidase assays provide quantitative evidence for the 
relative strength of the promoter. The average enzyme activity for pRK1388 was 
significantly lower than the enzyme activity of pRK1387 (27 ± 7 Miller Units and 133 ± 
32 Miller Units, respectively). The overall promoter activities of pRK1390 and pRK1391 
with 0276 insert (8 ± 1 Miller Units and 4.5 ± 0.5 Miller Units, respectively) were 
significantly lower than constructs containing orc0368. These assays confirm promoter 
activity and suggest the promoter created in orc368 is relatively weak. 
 A similar orc mutant characterized by Baugh et al, orc0367, contains a promoter 
located between the TR3 and TR4 transcription terminators as seen in Figure 20. Thus the 
newly created promoter is separated from the Q gene by a single terminator. The 
promoter in orc0367 was found to generate 16,400 Miller Activity Units, significantly 
more than the promoter found in orc368 [29]. 
We suggest that a stronger promoter is necessary to ensure enough readthrough of 
the terminator and expression of Q, the late gene regulator. In the case of the newly 
identified promoter in orc368, there is no known terminator between the new promoter 
Figure 20: Location of the promoter created in bacteriophage orc0367. The mutation that creates the promoter 
(indicated by a gray bar) is located between TR3 and TR4 (red arrows) and before the Q gene (green arrow, 
labeled). The location of the byp mutation in λ is indicated by the blue bar located after TR4 and before Q. The 
location of the nin3 and nin5 deletions is denoted by the set of brown bars. These deletions allow for N-
independent growth by removing TR2, TR3, and TR4 [29]. 
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and Q. Therefore, terminator readthrough events are not necessary for Q expression. Our 
results clearly show that a weaker promoter is sufficient to allow phage growth on the 
non-permissive rpoCY75N host. Previous publications have documented similar 
mutations in bacteriophage λ. The λ byp mutation also creates a promoter which, similar 
to the newly identified promoter in orc0368, occurs after TR4 in the λ genome (see Figure 
20) [28]. 
 It did not escape our attention that there was a three-fold difference in enzyme 
activity between constructs pRK1387 and pRK1388, even though both contained the 
same promoter sequence from orc0368 (see Table 7). Construct pRK1387, which 
contains an 86-base pair insert, had a higher enzyme activity than construct pRK1388, 
which contained a 130-base pair insert. Different insert lengths were used to ensure that 
all promoter elements were included. The difference in the cloned sequences can be seen 
in Figure 12. Although the two inserted sequences are of different lengths, they contain 
the same promoter sequence and therefore should not exhibit any difference in promoter 
activity at the transcriptional level. However, the extra downstream sequence in 
pRK1388 may play a role in the difference in enzyme activity. We suggest the observed 
difference in the measured enzyme activity is due to differences in translation efficiency. 
Translation in prokaryotes begins at a start codon, the bases AUG in the RNA 
which indicate an open reading frame (ORF), and is facilitated by another specific 
sequence called the Shine-Dalgarno site (E. coli sequence AGGAGGU) which helps the 
ribosome bind to the RNA [30]. The RNA sequence following the start codon encodes 
individual amino acids which are assembled in a specific order according to the RNA 
sequence as read by the ribosome. The order of these amino acids is important to the 
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structure of the protein product and is essential for the enzyme to function properly. The 
incorrect order of amino acids caused by the introduction of a new start codon or the 
occlusion of the Shine-Dalgarno site or start codon by RNA secondary structure can 
eliminate enzyme activity by disrupting translation of a functional enzyme [30]. 
If a new ORF was created by the extra downstream sequence included in 
pRK1388 it has the potential to interfere with normal translation of lacZ. The new ORF 
would cause lowered expression of functional β-galactosidase enzyme by allowing 
ribosomes to bind at an ORF other than the lacZ ORF, thereby interfering with translation 
of the functional enzyme by lowering the likelihood of ribosome binding to the lacZ 
ORF. Bioinformatic analysis using Geneious software to search for newly created ORFs 
in pRK1387 and pRK1388 suggested that no new ORFs were created. Therefore, it is not 
likely that a new ORF introduced by the insertion of sequence from RK815 x RK814 is 
responsible for the lower enzyme activity observed with construct pRK1388. 
Occlusion of the Shine-Dalgarno and start codon also has the potential to prevent 
the translation of the RNA into β-galactosidase. Occlusion of these sites could potentially 
occur because of secondary structure in the RNA. Just as RNA associates with itself to 
fold into the double stem-and-loop structure essential for RNA-mediated antitermination, 
RNA from the reporter vector may associate with itself. A site may be considered 
occluded if it exists within a strongly-associated region of paired bases in the predicted 
RNA secondary structure. 
To examine the possibility that the Shine-Dalgarno and/or start codon in 
pRK1388 are occluded by RNA secondary structure, the predicted mRNA transcripts 
were folded using Mfold software [31]. Different lengths of the initial transcribed 
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sequences from pRK1387and pRK1388 were folded. The calculated ΔG value indicates 
the spontaneity and stability of each proposed secondary structure; a lower ΔG indicates a 
higher likelihood of occurrence of the proposed structure in nature. The secondary 
structure with the lowest ΔG from each length of folded mRNA was used to assess 
occlusion of the Shine-Dalgarno and/or start codon. Representative structures with 
highlighted Shine-Dalgarno sequences and start codons are displayed in Figure 21.  
Secondary structures from sequences starting from the proposed TSS 
(transcription start site) to 10 base pairs beyond the start codon were used to assess 
occlusion of the Shine-Dalgarno site and start codon in pRK1387 and pRK1388. The 
proposed secondary structure from pRK1387 predicted a slightly occluded Shine-
Figure 21: Proposed RNA secondary structures for mRNA transcripts generated from the promoter probe 
constructs. Structures for pRK1387 (A) and pRK1388 (B) with 10 additional base pairs beyond the start codon 
included. In pRK1387 (A), the abbreviated Shine-Dalgarno site (red box, AGGA) is not strongly occluded and the 
start codon (green box, AUG) is completely accessible by the ribosome for translation. In pRK1388 (B), the 
abbreviated Shine-Dalgarno site (red box, AGGA) and the start codon (green box, AUG) are both occluded by 
complementary base pairing. Created using Mfold program. 
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Dalgarno site, paired at the two Guanine residues, and a fully accessible start codon 
(Figure 21). In contrast, the Shine-Dalgarno site in the predicted secondary structure for 
pRK1388 is base paired at all abbreviated constituent bases (AGGA). Additionally, the 
start codon in the predicted secondary structure of pRK1388 is occluded within a region 
of base pairs, making it inaccessible (Figure 21). 
The bioinformatic analysis supports our idea that the lower enzyme activity is not 
necessarily a reflection of the strength of the cloned promoter but rather a reflection of 
the ability of the ribosomes to access the ribosomal binding site within the transcribed 
RNA and synthesize a functional protein. There is no reason the inserted sequence in 
pRK1388 should contain a weaker promoter than the inserted sequence in pRK1387 as 
both contain the same predicted promoter sequence. However, an occluded Shine-









 The single base pair mutation at base pair 36,395 in orc0368 allows the 
bacteriophage to grow on the non-permissive host rpoCY75N E. coli by creating a 
promoter between the TR4 terminator and the phage Q gene. This promoter has an 
average activity of 133 ± 32 Miller Activity Units. In contrast, the same region from the 
parent phage 0276, which is incapable of growing on the rpoCY75N E. coli, produces 
only 4.5 ± 0.5 Miller Activity Units. We propose the newly identified promoter allows 
orc0368 to grow on the non-permissive host by completely bypassing the need for RNA-
mediated antitermination, a mechanism of antitermination blocked by the rpoCY75N E. 
coli. The mutation in orc0368 occurs in a location similar to the previously characterized 
byp mutations of bacteriophage λ [28,29]. 
 The newly created promoter in orc0386 eliminates the need to read through the 
TR1, TR2, TR3, or TR4 terminators. Instead, RNA polymerase can directly associate with 
the DNA template at the newly-formed promoter and transcription can proceed. We 
suggest that the new promoter allows expression of the Q gene, which in turn allows for 
expression of the late genes and phage growth on the host. The proposed model for this 






Figure 22: Proposed mechanism for growth on rpoCY75N E. coli. Antitermination fails and RNA polymerase 
dissociates from the template DNA at the terminators, stopping transcription. However, RNA polymerase re-
associates at the newly-formed promoter between the terminators and the Q gene and transcription of the genome 







SUGGESTIONS FOR FURTHER RESEARCH 
 
 Though the plaque morphology of orc0368 on rpoCY75N strain is similar to that 
of orc0368 on the wild type E. coli, the plaques are noticeably smaller on the rpoCY75N 
E. coli. One suggestion for further study would be to attempt to restore wild type plaque 
size by increasing the strength of the newly created promoter. This can be accomplished 
by bringing it closer to consensus promoter sequence by single base pair mutations. 
Increasing the strength of the promoter would theoretically increase the production of Q 
which would lead to increased production of the late genes, including those associated 
with cell lysis. Improved expression of Q and the late genes may lead to an increased 
plaque size on rpoCY75N over the same incubation period as compared to the plaques 
currently formed on rpoCY75N by orc0368. This study could also help determine the 
upper threshold strength of the promoter before it becomes so strong that Q is 
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Recipes for media used in this experiment are as follows: 
1. Luria Broth (LB), Lennox Recipe: combine the following—  
5 g NaCl (Fisher BioReagents; BP358-212) 
5 g Yeast Extract (BD; 212750) 
10 g Tryptone (Fisher BioReagents; BP9726-500) 
1 L DI H2O 
 
—Heat to dissolve, aliquot 100 mL to 125 mL screw-cap glass bottles. 
Autoclave. Store at room temperature 
2. Luria Broth with Ampicillin, Lennox Recipe: make LB as described in (1), add 
100 μg/mL Ampicillin (Fisher BioReagents; BP-1760-25) prior to use. Store at 
4°C for up to 21 days. 
3. 50X TAE: combine the following— 
 
242 g Tris-base (Fisher BioReagents; M-11645) 
57.1 mL Glacial Acetic Acid (Amresc; 0714-4L) 
100 mL 0.5 M EDTA (Sigma; E-5134) 
 
—Dilute to 1 L total volume using DI H2O. Store at room temperature. 
4. 1X TAE: add 20 mL 50X TAE to 980 mL DI H2O, store at room temperature. 
5. Loading Dye: combine the following in % weight/volume in a 15 mL tube— 
 
0.25% Bromophenol Blue (Sigma-Aldrich; CAS: 115-39-9) 
0.25% Xylene Cyanol FF (Research Organics; 7113X) 
30% Glycerol (Fisher Chemical; CAS: 56-81-5) 
 
—Aliquot 1 mL in 1.5 mL microcentrifuge tubes. Store at room temperature. 
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6. PCR Mix: combine the following in a 1.5 mL microcentrifuge tube— 
 
6 μL 10 mM dATP (Fisher Scientific Kit; FB-6000-10) 
6 μL 10 mM dCTP (Fisher Scientific Kit; FB-6000-10) 
6 μL 10 mM dGTP (Fisher Scientific Kit; FB-6000-10) 
6 μL 10 mM dTTP (Fisher Scientific Kit; FB-6000-10) 
330 μL 10X Buffer A (Fisher Scientific Kit; FB-6000-10) 
 
—Store at -20°C, keep on ice during use. 
7. Super Optimal Broth (SOC Broth): combine the following— 
 
20 g Tryptone (Fisher BioReagents; BP9726-500) 
5 g Yeast Extract (BD; 212750) 
0.5 g NaCl (Fisher BioReagents; BP358-212) 
1.25 mL 2 M KCl (Acros; CAS: 744-40-7) 
10 mL 1 M MgCl2 (Fisher Chemical; M13448) 
1 L DI H2O 
 
—Heat to dissolve, aliquot 100 mL into 125 mL screw-cap glass bottles. 
Autoclave and cool to room temperature. Add 1 mL 1 M MgSO4 (Sigma; M-
2773) and 2 mL glucose (Fisher Scientific; D16500) prior to use. Store at 
room temperature. 
8. MacConkey-Lactose-Ampicillin Plates: combine the following— 
 
50 g Difco MacConkey Agar (Difco; 281810) 
1 L DI H2O 
 
—Heat to dissolve. Autoclave and cool to 55°C. Add 100 μg/mL Ampicillin 
(Fisher BioReagents; BP-1760-25). Pour into petri plates (USA Scientific; 
100x15mm; 8609-0010), let cool and harden for 2 days. Store inside plate 
sleeve at 4°C for up to 21 days. 
9. Z-buffer: combine the following— 
 
16.1 g Na2HPO4 ● 7H2O (Sigma-Aldrich; 7782-85-6) 
5.5 g NaH2PO4 ● H2O (Sigma-Aldrich; 10049-21-5) 
0.75 g KCl (Acros; CAS: 744-40-7) 
0.246 g MgSO4 ● H2O (Sigma-Aldrich; 10034-99-8) 
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2.7 mL β-mercaptoethanol (SigmaAldrich; M-3148) 
1 L DI H2O 
 
—Dissolve salts in water, adjust pH to 7.0. Do not autoclave. Store at 4°C. 
10. 10% Sodium-Dodecyl-Sulfate (SDS): combine the following in a 15 mL tube— 
 
1 g SDS (Sigma-Aldrich; L6026) 
10 mL DI H2O 
 
—Dissolve SDS in water, equilibrating in 55°C water bath to facilitate as 
necessary. Store at room temperature.  
